New insulin combo aims to tame blood sugar in Tough-to-Treat diabetes
NCT ID NCT07307235
First seen Jun 27, 2026 · Last updated Jul 08, 2026 · Updated 2 times
Summary
This study compares a new injectable medicine called iGlarLixi with standard diabetes treatments in adults with type 2 diabetes whose blood sugar is not well controlled by pills alone. About 1,300 people in China will take part. The goal is to see if iGlarLixi helps lower blood sugar more safely and effectively than usual care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affiliated Nanhua Hospital, University of South China
RECRUITINGHengyang, Hunan, 421002, China
-
Heilongjiang Provincial Hospital
RECRUITINGHarbin, Heilongjiang, 150036, China
-
Hengyang Central Hospital
RECRUITINGHengyang, Hunan, 421001, China
-
Hunan Provincial People's Hospital / The First Affiliated Hospital of Hunan Normal University
RECRUITINGChangsha, Hunan, 410005, China
-
Jiaxing First Hospital
RECRUITINGJiaxing, Zhejiang, 314001, China
-
Minhang Hospital, Fudan University / Central Hospital of Minhang District, Shanghai
RECRUITINGShanghai, Shanghai Municipality, 201199, China
-
Ningbo Medical Center Lihuili Hospital
RECRUITINGNingbo, Zhejiang, 315040, China
-
Ningbo No. 2 Hospital
RECRUITINGNingbo, Zhejiang, 315010, China
-
Shanghai East Hospital, Tongji University
RECRUITINGShanghai, Shanghai Municipality, 200120, China
-
Shanghai Pudong New Area Punan Hospital
RECRUITINGShanghai, Shanghai Municipality, 200125, China
-
Shanghai Qingpu District Central Hospital / Qingpu Branch of Zhongshan Hospital, Fudan University
RECRUITINGShanghai, Shanghai Municipality, 201700, China
-
Shanghai Tenth People's Hospital / Tenth People's Hospital of Tongji University
RECRUITINGShanghai, Shanghai Municipality, 200072, China
-
Shanghai Tongren Hospital, Shanghai Jiao Tong University School of Medicine
RECRUITINGShanghai, Shanghai Municipality, 200336, China
-
Shenzhen Third People's Hospital
RECRUITINGShenzhen, Guangdong, 518112, China
-
The First Affiliated Hospital of Anhui Medical University
RECRUITINGHefei, Anhui, 230022, China
-
The First Affiliated Hospital of USTC / Anhui Provincial Hospital
RECRUITINGHefei, Anhui, 230001, China
-
The First Clinical Hospital of Jilin Academy of Chinese Medicine Sciences
RECRUITINGChangchun, Jilin, 130021, China
-
The First People's Hospital of Huizhou
RECRUITINGHuizhou, Guangdong, 516003, China
-
The Second Affiliated Hospital of Nanchang University
RECRUITINGNanchang, Jiangxi, 330006, China
-
The Second Affiliated Hospital of Nanjing Medical University
RECRUITINGNanjing, Jiangsu, 210003, China
-
Wuhan Fourth Hospital / Wuhan Puai Hospital
RECRUITINGWuhan, Hubei, 430030, China
-
Xinxiang Central Hospital
RECRUITINGXinxiang, Henan, 453003, China
-
Zhejiang Provincial People's Hospital
RECRUITINGHangzhou, Zhejiang, 310014, China
-
Zhongshan Hospital, Fudan University
RECRUITINGShanghai, Shanghai Municipality, 200032, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a single pill tackle both fatty liver and diabetes?
- Does when you eat carbs and protein reshape blood sugar control?